delta-9-tetrahydrocannabinol en es it fr

delta-9-tetrahydrocannabinol Brand names, delta-9-tetrahydrocannabinol Analogs

delta-9-tetrahydrocannabinol Brand Names Mixture

  • No information avaliable

delta-9-tetrahydrocannabinol Chemical_Formula


delta-9-tetrahydrocannabinol RX_link

delta-9-tetrahydrocannabinol fda sheet

delta-9-tetrahydrocannabinol FDA

delta-9-tetrahydrocannabinol msds (material safety sheet)

delta-9-tetrahydrocannabinol MSDS

delta-9-tetrahydrocannabinol Synthesis Reference

No information avaliable

delta-9-tetrahydrocannabinol Molecular Weight

314.462 g/mol

delta-9-tetrahydrocannabinol Melting Point

200 oC at 2.00E-02 mm Hg

delta-9-tetrahydrocannabinol H2O Solubility

2.8 mg/ml

delta-9-tetrahydrocannabinol State


delta-9-tetrahydrocannabinol LogP


delta-9-tetrahydrocannabinol Dosage Forms


delta-9-tetrahydrocannabinol Indication

For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments

delta-9-tetrahydrocannabinol Pharmacology

Dronabinol may has complex effects on the central nervous system (CNS), including cannabinoid receptors. Dronabinol may inhibit endorphins in the emetic center, suppress prostaglandin synthesis, and/or inhibit medullary activity through an unspecified cortical action.

delta-9-tetrahydrocannabinol Absorption

90 - 95%

delta-9-tetrahydrocannabinol side effects and Toxicity

No information avaliable

delta-9-tetrahydrocannabinol Patient Information

delta-9-tetrahydrocannabinol Organisms Affected

Humans and other mammals